Abstract

Variceal haemorrhage is a life-threatening condition requiring prompt emergency therapy. This paper summarises the key aspects of management of this condition in the acute setting, including airway management, fluid resuscitation, and pharmacotherapy. The value of therapeutic endoscopy, balloon tamponade and radiological shunt procedures are also highlighted.
[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Beppu K, Inokuchi K, Koyanagi N, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc. 1981;27: 213-8.
2. NIEC. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med. 1988; 319: 983-9.
3. Fisher NC, Hanson J, Phillips A, Rao JN, Swarbrick ET. Mortality from liver disease in the West Midlands, 1993-2000: observational study. Bmj. 2002;325: 312-3.
4. MacMathuan P, Westaby D, Williams R. Portal Hypertension: Pathophysiology, Diagnosis and Treatment. In: Millward-Sadler HG, Wright R, Arthur MJP, eds. Wright's Liver and Biliary Disease. London: W.B. Saunders; 1992: 1296-1322.
5. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60: 646-9.
6. Lebrec D, Poynard T, Bernuau J, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology. 1984; 4: 355-8.
7. Kingham JG, Levison DA, Stansfeld AG, Dawson AM. Non-cirrhotic intrahepatic portal hypertension: A long term follow-up study. Q J Med. 1981; 50: 259-68.
8. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980; 79: 1139-44.
9. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99:1401-7.
10. Bernstein DE, Jeffers L, Erhardtsen E, et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology. 1997; 113: 1930-7.
11. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut. 2000;46 Suppl 3 4:III1-III15.
12. Stiegmann GV, Goff JS, Michaletz-Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992; 326: 1527-32.
13. Terblanche J, Yakoob HI, Bornman PC, et al. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg. 1981;194: 521-30.
14. Johnston GW, Rodgers HW. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg. 1973; 60: 797-800.
15. Ramond MJ, Valla D, Mosnier JF, et al. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology. 1989;10:488-93.
16. Soehendra N, Grimm H, Nam VC, Berger B. N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy. 1987;19: 221-4.
17. Westaby D, Polson R, Gimson A, Hayes P, Williams R. Comparison of propranolol with injection sclerotherapy in prevention of rebleeding from oesophageal varices in cirrhotic patients. Drugs. 1989; 37: 42-6.
18. Westaby D, Melia W, Hegarty J, Gimson AE, Stellon AJ, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology. 1986; 6: 673-5.
19. Morgan JS, Groszmann RJ. Somatostatin in portal hypertension. Dig Dis Sci. 1989; 34: 40S-47S.
20. McCormick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK. Clinical vs haemodynamic response to drugs in portal hypertension. J Hepatol. 1998; 28: 1015-9.
21. Burroughs AK, Patch DW. Management of variceal haemorrhage in cirrhotic patients. Gut. 2001; 48: 738-40.
22. Gimson AE, Westaby D, Hegarty J, Watson A, Williams R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology. 1986; 6: 410-3.
23. Freeman JG, Cobden I, Record CO. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol. 1989; 11: 58-60.
24. Jones DB. Variceal Haemorrhage. In: Irvine EJ, Hunt RH, eds. EvidenceBased Gastroenterology. London: BC Decker; 2001:408-421.
25. Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology. 2001; 120: 946-54.
26. Panes J, Teres J, Bosch J, Rodes J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci. 1988; 33: 454-9.
27. Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol. 2001; 35: 590-7.
28. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. Salvage transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology. 1998; 114: 981-7.